Roche Holding AG (RHHBY) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Basel, スイス. 現CEOは Thomas Schinecker.
RHHBY を有する IPO日 2003-08-20, 103,249 名の正社員, に上場 Other OTC, 時価総額 $328.61B.
Roche Holding AG is a Swiss multinational pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular and metabolism, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. In addition to pharmaceuticals, Roche operates a substantial diagnostics business offering in vitro tests for disease diagnosis including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. The company serves patients and healthcare providers across Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and numerous other markets globally.
